Global Chronic Fatigue Syndrome Therapeutics Market: Overview

Chronic fatigue syndrome, also known as Myalgic encephalomyelitis, is a chronic disease which lasts for six months and affects the central nervous system and the immune system. The disease leads to musculoskeletal disorders, impairment of long term memory, and disturbed sleep patterns. This results in substantial decline in social, occupational, educational, and personal activity among patients. There are no specific biomarkers or tests to diagnose chronic fatigue syndrome. Symptoms include sore throat, muscle pain, headache, and fatigue, which continues for months or years. Diagnosis is difficult; however, certain blood tests are performed to understand the conditions such as infections, and liver and thyroid abnormalities to gauge patient’s condition. Children and adolescents are likely to recover at a faster pace than adults. This syndrome is likely to affect people in the 40 to 50 age group and stress is one of the major risk factors for developing this syndrome.

Global Chronic Fatigue Syndrome Therapeutics Market: Key Trends

Rise in awareness about chronic fatigue syndrome and treatment through medications and therapies to manage the syndrome is expected to drive the global chronic fatigue syndrome therapeutics market. Various organizations are collaborating to create awareness and bridge the gap to understand the symptoms and management of chronic fatigue syndrome. Key players are investing in the development of treatments for this condition. These factors are projected to propel the global market. However, underdiagnoses of the syndrome in both developed and developing countries acts as a major restraint of the global market. This results in improper information about the prevalence and incidence in developing countries. Moreover, improper diagnostic tools could hamper market growth. Various initiatives are being taken by governments which enable companies to discover treatments for this syndrome. According to research published on Virtual Medical Centre, in 2018, incidence of chronic fatigue syndrome in Australia was around 0.3% or 30 per 100,000 people. However, the number fluctuates between 100 and 200 per 100,000. Chronic fatigue syndrome is most common in women and is likely to affect 2 to 4 times more women than men. Underdiagnoses of the syndrome is a major issue and prevalence of chronic fatigue syndrome is unknown in Europe.

Global Chronic Fatigue Syndrome Therapeutics Market: Segmentation

The global chronic fatigue syndrome therapeutics market can be segmented based on drug class, mode, distribution channel, and region. In terms of drug class, the market can be classified into antimicrobials & immune enhancers, sleep enhancing drugs, CNS stimulants, and others. Based on mode, the global chronic fatigue syndrome therapeutics market can be categorized into prescription drugs and OTC drugs. There is no cure for the disorder; however, medications mentioned above are recommended to patients to help manage symptoms and thus improving their quality of life. In terms of distribution channel, the market can be divided into hospital pharmacies, retails pharmacies, and online pharmacies.

Global Chronic Fatigue Syndrome Therapeutics Market: Regional Analysis

In terms of region, the global chronic fatigue syndrome therapeutics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2018, and the trend is projected to continue during the forecast period. The region’s dominance of the global market is due to rise in awareness about the treatment of chronic fatigue syndrome, increase in health care expenditure, and favorable reimbursement policies. Moreover, advanced health care facilities and recent approval of drugs by the FDA boost the growth of the chronic fatigue syndrome therapeutics market in the U.S. As the exact cause of this syndrome is unknown, the FDA is actively involved in discovering the correct diagnosis and hence an effective treatment of the disease. This is likely to boost the chronic fatigues therapeutics market in the region. According to the Institute of Medicine (IOM) report in 2015, an estimated 836,000 to 2.5 million people in the U.S. suffer from chronic fatigue syndrome. The chronic fatigue syndrome therapeutics market in Asia Pacific is anticipated to grow at a rapid pace during the forecast period. Rise in prevalence of chronic fatigue syndrome in the past few years, increase in awareness about the disease, and government initiatives to discover the source and approve the treatment are the factors fueling the growth of the market in the region. Research activities conducted by institutions to derive drugs are expected to augment the chronic fatigue syndrome therapeutics market in Asia Pacific.

Global Chronic Fatigue Syndrome Therapeutics Market: Competitive Landscape

Key players operating in the global chronic fatigue syndrome therapeutics market include Hemispherx Biopharma, GP Pharm, USV, Cadila Pharmaceuticals, Goodfellow Pharma, and Torrent Labs.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Chronic Fatigue Syndrome Therapeutics Market

Pre Book